Benzinga's Top Initiations - AC Immune (NASDAQ:ACIU), AbbVie (NYSE:ABBV)

Analysts at Credit Suisse initiated coverage of Sarepta Therapeutics Inc SRPT with an Outperform rating. The price target for Sarepta is set to $68. Sarepta shares closed at $48.94 on Monday.
Analysts at Bank of America initiated coverage of 8Point3 Energy Partners LP CAFD with a Buy rating. 8Point3 Energy Partners shares closed at $14.44 on Monday.
Analysts at Baird initiated coverage on Johnson Controls International plc JCI with an Outperform rating. The price target for Johnson Controls is set to $53. Johnson Controls shares closed at $43.74 on Monday.
Analysts at Rosenblatt initiated coverage on salesforce.com, inc. CRM with a Buy rating. The price target for salesforce.com is set to $90. salesforce.com shares closed at $72.83 on Monday.
Needham initiated coverage on Neurocrine Biosciences, Inc. NBIX with a Buy rating. The price target for Neurocrine Biosciences is set to $62. Neurocrine Biosciences shares closed at $42.30 on Monday.
Analysts at Evercore ISI Group initiated coverage on Paypal Holdings Inc PYPL with a Buy rating. The price target for Paypal is set to $46. Paypal shares closed at $39.48 on Monday.
Analysts at Gabelli & Co. initiated coverage on Manchester United PLC MANU with a Buy rating. Manchester United shares closed at $15.85 on Monday.
Credit Suisse initiated coverage on AC Immune Ltd ACIU with an Outperform rating. The price target for AC Immune is set to $18. AC Immune shares closed at $14.43 on Monday.
Analysts at Wells Fargo initiated coverage on Costco Wholesale Corporation COST with a Market Perform rating. Costco shares closed at $148.70 on Monday.
Leerink Swann initiated coverage on AbbVie Inc ABBV with a Market Perform rating. AbbVie shares closed at $60.14 on Monday.

Market News and Data brought to you by Benzinga APIs